Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Merkel

Showing results (41-50 of 434) with videos related to

Pageof 44
Sort By:
Annals of the Rheumatic Diseases|November 30, 2016
Infections and the risk of incident giant cell arteritis: a population-based, case-control studyRennie L Rhee, Peter C Grayson, Peter A Merkel, et al.
Arthritis Care & Research|November 5, 2016
Variation in the Treatment of Children Hospitalized With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in the USKaren E James, Rui Xiao, Peter A Merkel, et al.
Annals of the Rheumatic Diseases|January 19, 2017
Response to eLetter: 'Infections in giant cell arteritis and therapeutic implications' by Moiseev <i>et al</i>Rennie L Rhee, Peter C Grayson, Peter A Merkel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 29, 2014
Reply: To PMID 23740775Lindsay A Farrer, Richard Sherva, Peter A Merkel, et al.
Provider (Washington, D.C.)|July 30, 2016
Reenergizing Research While Improving Patient CareW Benjamin Nowell, Peter A Merkel, Laura E Schanberg, et al.
Rheumatology (Oxford, England)|January 28, 2021
Venous thromboembolism in ANCA-associated vasculitis: a population-based cohort studyMatina Liapi, David Jayne, Peter A Merkel, et al.
Arthritis Care & Research|April 1, 2011
A woman with severe lupus nephritis and difficult to control diabetes mellitusIrina Buhaescu, Soo Rhee, Michael R York, et al.
JMIR Research Protocols|February 24, 2020
Evaluation of the Safety and Efficacy of Avacopan, a C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/Azathioprine: Protocol for a Randomized, Double-Blind, Active-Controlled, Phase 3 TrialPeter A Merkel, David R Jayne, Chao Wang, et al.
The Journal of Rheumatology|June 3, 2016
Comorbidities in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis versus the General PopulationMartin Englund, Peter A Merkel, Gunnar Tomasson, et al.
The Journal of Rheumatology|June 3, 2016
Visual Complications in Patients with Biopsy-proven Giant Cell Arteritis: A Population-based StudyMuna Saleh, Carl Turesson, Martin Englund, et al.
Pageof 44

Showing results (41-50 of 434) with videos related to

Sort By:
Pageof 44
Annals of the Rheumatic Diseases|November 30, 2016
Infections and the risk of incident giant cell arteritis: a population-based, case-control studyRennie L Rhee, Peter C Grayson, Peter A Merkel, et al.
Arthritis Care & Research|November 5, 2016
Variation in the Treatment of Children Hospitalized With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in the USKaren E James, Rui Xiao, Peter A Merkel, et al.
Annals of the Rheumatic Diseases|January 19, 2017
Response to eLetter: 'Infections in giant cell arteritis and therapeutic implications' by Moiseev <i>et al</i>Rennie L Rhee, Peter C Grayson, Peter A Merkel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 29, 2014
Reply: To PMID 23740775Lindsay A Farrer, Richard Sherva, Peter A Merkel, et al.
Provider (Washington, D.C.)|July 30, 2016
Reenergizing Research While Improving Patient CareW Benjamin Nowell, Peter A Merkel, Laura E Schanberg, et al.
Rheumatology (Oxford, England)|January 28, 2021
Venous thromboembolism in ANCA-associated vasculitis: a population-based cohort studyMatina Liapi, David Jayne, Peter A Merkel, et al.
Arthritis Care & Research|April 1, 2011
A woman with severe lupus nephritis and difficult to control diabetes mellitusIrina Buhaescu, Soo Rhee, Michael R York, et al.
JMIR Research Protocols|February 24, 2020
Evaluation of the Safety and Efficacy of Avacopan, a C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/Azathioprine: Protocol for a Randomized, Double-Blind, Active-Controlled, Phase 3 TrialPeter A Merkel, David R Jayne, Chao Wang, et al.
The Journal of Rheumatology|June 3, 2016
Comorbidities in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis versus the General PopulationMartin Englund, Peter A Merkel, Gunnar Tomasson, et al.
The Journal of Rheumatology|June 3, 2016
Visual Complications in Patients with Biopsy-proven Giant Cell Arteritis: A Population-based StudyMuna Saleh, Carl Turesson, Martin Englund, et al.
Pageof 44